Men's Health: The Market for Current and Emerging Drug Therapies, 2nd Edition

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,550	234 Pages	Kalorama Information	May, 2006	KLI1190816

Best Price Guarantee
Price	from $3,550
Length	234 Pages
Publisher	Kalorama Information
Published Date	May, 2006
SKU	KLI1190816

Table of Contents
Description

This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments:

Men’s Cancer
Men’s Sexual Dysfunction
Men’s Sexually Transmitted Diseases
Men’s Urinary Conditions
Andropause

The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic hyperplasia (BPH), urinary incontinence, and STD’s such as HIV, herpes, and genital warts. For each segment, revenues and forecasts are made by type of drug through 2010; competitive market share of the leading suppliers are estimated for 2005 and projected to 2010 based on likely market entrants and patent expiry; and a geographical breakdown (U.S. vs non-U.S.) is provided through 2010.

The report includes epidemiologic information on the various conditions (U.S. and worldwide) and reviews the issues and trends—business, clinical, regulatory, and social—that are shaping the future of this market.

Executive Summary
- INTRODUCTION
- SCOPE AND METHODOLOGY
- SIZE AND GROWTH OF THE MARKET
  - Table The World Market for Men's Health Prescription Drugs 2003-2010
- ISSUES AND TRENDS AFFECTING MARKET
- LEADING COMPETITORS
Introduction
- HISTORY AND GROWTH OF THE MEN'S HEALTH INDUSTRY
- MALE ANATOMY
- MALE REPRODUCTIVE PHYSIOLOGY
- MALE DEMOGRAPHICS AND STATISTICS
  - Table World Male Population by Selected Geographical Region 2005-2050
  - Table Life Expectancy at Birth by Selected Countries, 2000
  - Table United States Life Expectancy at Birth, 1990-2000, and
  - Table Estimated Male Prevalence of Selected Risk Behavior by Geographical Region, 2005
Men's Cancer
- OVERVIEW
  - Description of Cancers Affecting Men
  - Prevalence and Incidence
    - Table Men's Cancer: Estimated World Incidence and Prevalence
- DESCRIPTION OF PRODUCTS
  - Hormone Therapies
  - Chemotherapy Agents
  - Brachytherapy
- RESEARCH AND DEVELOPMENT
  - Table Research and Development in Men's Cancer Therapies
- MARKET SIZE AND GROWTH
  - World Market
    - Table The World Market Men's Health: Men's Cancer Therapies by
  - U.S. Market
    - Table The U.S. Market Men's Cancer Therapies
  - Non-U.S. Market
    - Table The International (Non-U.S.) Market for Men's Cancer Therapies
- COMPETITIVE ANALYSIS
  - Table Leading Suppliers' Revenues and Market Shares of the World
Male Sexual Dysfunction
- OVERVIEW
  - Description of Sexual Disorders Affecting Men
  - Prevalence and Incidence
    - Table Estimated World and U.S. Incidence and Prevalence of
- DESCRIPTION OF PRODUCTS
  - Phosphodiesterase Type V Inhibitors (PDE-5 Inhibitors)
    - Table PDE-5 Inhibitor Comparison Chart
  - Others
- RESEARCH AND DEVELOPMENT
  - Table Research and Development in Men's Sexual Dysfunction
- MARKET SIZE AND GROWTH
  - World Market
    - Table The World Market Men's Sexual Dysfunction Therapies by
  - U.S. Market
    - Table The U.S. Market for Men's Sexual Dysfunction Therapies
  - Non-U.S. Market
    - Table The International (Non-U.S.) Market for
- COMPETITIVE ANALYSIS
  - Table Leading Suppliers' Revenues and Market Shares of the World
Sexually Transmitted Diseases
- OVERVIEW
  - Description of Sexually Transmitted Diseases Affecting Men
  - Prevalence and Incidence
    - Table Men's Sexually Transmitted Diseases: Estimated World Incidence and Prevalence for Men (in thousands)
- DESCRIPTION OF PRODUCTS
  - Antibiotics
  - Antiviral Therapies
  - Others
- RESEARCH AND DEVELOPMENT
  - Table Research and Development in
- MARKET SIZE AND GROWTH
  - World Market
    - Table The World Market Men's Sexually Transmitted Disease Therapies by Product Type (Antibiotics, Antivirals, Others)
  - U.S. Market
    - Table The U.S. Market Men's Sexually Transmitted Disease Therapies
  - Non-U.S. Market
    - Table The International (Non-U.S.) Market for
- COMPETITIVE ANALYSIS
  - Table Leading Suppliers' Revenues and Market Shares of the World
Men's Urinary Conditions
- OVERVIEW
  - Description of Urinary Conditions Affecting Men
  - Prevalence and Incidence
    - Table Estimated World Incidence and Prevalence for Men's Urinary
- DESCRIPTION OF PRODUCTS
  - Alpha Blockers
  - 5-Alpha Reductase Inhibitors
  - Anticholinergics
  - Antispasmodics and Others
- RESEARCH AND DEVELOPMENT
  - Table Research and Development in
- MARKET SIZE AND GROWTH
  - World Market
    - Table The World Market Men's Urinary Condition Therapies by
  - U.S. Market
    - Table The U.S. Market for Men's Urinary Condition Therapies
  - Non-U.S. Market
    - Table The International (Non-U.S.) Market for
- COMPETITIVE ANALYSIS
  - Table Leading Suppliers' Revenues and Market Shares of the World
Male Menopause or Andropause
- OVERVIEW
  - Description of Male Menopause
  - Prevalence and Incidence
    - Table Estimated World Incidence and Prevalence of Andropause
- DESCRIPTION OF PRODUCTS
- RESEARCH AND DEVELOPMENT
  - Table Research and Development in
- MARKET SIZE AND GROWTH
  - World Market
    - Table The World Market for Andropause Therapies
  - U.S. Market
    - Table The U.S. Market for Andropause Therapies
  - Non-U.S. Market
    - Table The International (Non-U.S.) Market for Andropause Therapies
- COMPETITIVE ANALYSIS
  - Table Leading Suppliers' Revenues and Market Shares of the World
Issues and Trends Affecting the Men's Health Market
- INTRODUCTION
- EDUCATION AND AWARENESS OF MEN'S HEALTH
- OFFICE OF MEN'S HEALTH
- CHANGING LIFE EXPECTANCY
- DIABETES AND SLEEP
- EARLY DETECTION AND SCREENING OF PROSTATE CANCER
  - Table Relative Risk Related to Family History of Prostate Cancer
- BLACKS AND PROSTATE CANCER
- ERECTILE DYSFUNCTION AND CAD
- COSMETIC SURGERY
- BLADDER CANCER DETECTION
- LIFESTYLE CHANGES AND PROSTATE CANCER
- EFFECTS OF TESTOSTERONE DOSAGE ON BEHAVIOR OF OLDER MEN
- TESTOSTERONE REPLACEMENT THERAPY DECREASES FAT AND INCREASES MUSCLE
- MEN OF ALL AGES RESPOND TO BUILDING MUSCLE MASS WITH TESTOSTERONE DOSES
Market Summary
- OVERVIEW
- MARKET SIZE AND FORECAST
  - World Market
    - Table The World Market for Men's Health Prescription Drugs
  - Markets by Segments
    - Table The World Market for Men's Health Prescription Drugs by
- COMPETITOR ANALYSIS
  - Table Leading Suppliers and Significant Segments of Participation
- MARKET OUTLOOK
Corporate Profiles
- INTRODUCTION
- CURRENT MARKET LEADERS PROFILES
- ABBOTT LABORATORIES
- ASTELLAS PHARMA INC.
- ALZA CORPORATION
- ASTRAZENECA PLC
- BAYER CORPORATION
- BOEHRINGER INGELHEIM GMBH
- BRISTOL-MYERS SQUIBB COMPANY
- ELI LILLY & COMPANY
- GLAXOSMITHKLINE PLC
- MERCK & COMPANY, INC.
- PFIZER, INC.
- ROCHE GROUP
- SANOFI-AVENTIS
- TAKEDA CHEMICAL INDUSTRIES, LTD.
- TAP PHARMACEUTICAL PRODUCTS, INC.
- UNIMED PHARMACEUTICALS, INC.
- VIVUS, INC.
- WATSON PHARMACEUTICALS, INC.
Company Directory